1000 Coloplast employees to give Atos flying start in China

On Monday, Coloplast announced the acquisition of Atos Medical for DKK 16bn (USD 2.5bn). The plan now is to grow the Swedish company in a number of global markets, says President and CEO at Coloplast Kristian Villumsen, who highlights the two companies' synergies in China, where Atos has multiple upcoming product launches.
Photo: CHINA DAILY/via REUTERS / X01745
Photo: CHINA DAILY/via REUTERS / X01745
BY ULRICH QUISTGAARD, TRANSLATED BY DANIEL PEDERSEN

Coloplast's President and CEO Kristian Villumsen eyes global growth opportunities in Atos Medical, which the Danish medtech company has just acquired for DKK 16bn (USD 2.5bn).

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading